The immune response to insulin serves as a valuable model system for studying T cell recognition, antigen processing, and genetic regulation of immunity. Work done previously on this project lead to the discovery that disulfide reduction occurs during antigen processing and that T cells can recognize thiol-dependent epitopes. Disulfide reduction is both necessary and sufficient for binding of insulin peptides to class Il MHC and recognition by helper T cells. The mechanism responsible for disulfide reduction in the endocytic compartments of APC is unknown and will be investigated in specific aim 1, with the goal of identifying the intracellular compartments where reduction occurs and characterizing cofactors that may participate. Experiments with insulin B chain have demonstrated that peptides can bind to an alternative site in class Il MHC outside of the peptide-binding groove. The functional significance of alternative peptide/MHC complexes will be investigated in aim 2. Additional experiments in aim 2 will be done to characterize insulin T cell determinants with emphasis on the role of cysteines as MHC anchors or TCR contact residues.
Specific aim 3 is to investigate a novel antigen processing pathway used by APC to present soluble insulin to Qa-1- restricted T cells, to study the peptide specificity of Qa-1 and specific T cells, and to explore the function of Qa-1-restricted T cells in the immune response to insulin. It is expected that the proposed study will broaden our general understanding of antigen processing, our knowledge of the peptide/MHC ligands that can be recognized by T cells, and the role of nonclassical class I molecules in immunity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI033614-06
Application #
2672190
Study Section
Immunobiology Study Section (IMB)
Project Start
1993-07-01
Project End
2001-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Emory University
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Zhou, Zemin; Reyes-Vargas, Eduardo; Escobar, Hernando et al. (2017) Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing. Eur J Immunol 47:314-326
Zhou, Zemin; Reyes-Vargas, Eduardo; Escobar, Hernando et al. (2016) Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides. Eur J Immunol 46:834-45
Chen, Lili; Reyes-Vargas, Eduardo; Dai, Hu et al. (2014) Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity. J Immunol 193:1427-39
Gu, Yapeng; Jensen, Peter E; Chen, Xinjian (2013) Immunodeficiency and autoimmunity in H2-O-deficient mice. J Immunol 190:126-37
Chen, Lili; Jay, David C; Fairbanks, Jared D et al. (2011) An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus. J Immunol 187:6463-72
Zhou, Zemin; Callaway, Kari A; Weber, Dominique A et al. (2009) Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes. J Immunol 183:4187-91
Swanson 2nd, Phillip A; Pack, Christopher D; Hadley, Annette et al. (2008) An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. J Exp Med 205:1647-57
Escobar, Hernando; Crockett, David K; Reyes-Vargas, Eduardo et al. (2008) Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs. J Immunol 181:4874-82
Jay, David C; Reed-Loisel, Lisa M; Jensen, Peter E (2008) Polyclonal MHC Ib-restricted CD8+ T cells undergo homeostatic expansion in the absence of conventional MHC-restricted T cells. J Immunol 180:2805-14
Chen, Xinjian; Reed-Loisel, Lisa M; Karlsson, Lars et al. (2006) H2-O expression in primary dendritic cells. J Immunol 176:3548-56

Showing the most recent 10 out of 39 publications